Suchergebnisse - "Giganti, Mark J"

PubPharm (57)

1

Systemic inflammation in pregnant women with HIV : relationship with HIV treatment regimen and preterm delivery

enthalten in: AIDS (London, England) | 2024

von Shivakoti, R. | Giganti, M. | Lederman, M. | +13

2

Response to Drs. de Grooth and Parienti

enthalten in: The Journal of infectious diseases | 2024

von Giganti, M. | Chew, K. | Eron, J. | +3

3

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19 : a randomized, controlled, phase II trial

enthalten in: EClinicalMedicine | 2023

von Jagannathan, P. | Chew, K. | Giganti, M. | +114

4

One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019 : A Randomized Controlled Phase 2 Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Jilg, N. | Chew, K. | Giganti, M. | +62

5

Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19

enthalten in: The Journal of infectious diseases | 2023

von Giganti, M. | Chew, K. | Eron, J. | +34

6

Variant-Specific Viral Kinetics in Acute COVID-19

enthalten in: The Journal of infectious diseases | 2023

von Ribeiro, R. | Choudhary, M. | Deo, R. | +28

7

Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials

enthalten in: The Journal of infectious diseases | 2023

von Moser, C. | Chew, K. | Giganti, M. | +26

UpdateOf: medRxiv. 2023 Mar 17;:. - PMID 36993419

8

Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19

enthalten in: The Journal of infectious diseases | 2023

von Taiwo, B. | Chew, K. | Moser, C. | +44

9

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

enthalten in: Annals of internal medicine | 2023

von Evering, T. | Chew, K. | Giganti, M. | +125

10

Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19 : 2 Randomized Clinical Trials

enthalten in: JAMA network open | 2023

von Bender Ignacio, R. | Chew, K. | Moser, C. | +49

1
2
3
4
5
6
Nächster »
[6]